2-149575863-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015702.3(MMADHC):​c.479-22G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.76 in 1,553,354 control chromosomes in the GnomAD database, including 458,468 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 35624 hom., cov: 33)
Exomes 𝑓: 0.77 ( 422844 hom. )

Consequence

MMADHC
NM_015702.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.14

Publications

8 publications found
Variant links:
Genes affected
MMADHC (HGNC:25221): (metabolism of cobalamin associated D) This gene encodes a mitochondrial protein that is involved in an early step of vitamin B12 metabolism. Vitamin B12 (cobalamin) is essential for normal development and survival in humans. Mutations in this gene cause methylmalonic aciduria and homocystinuria type cblD (MMADHC), a disorder of cobalamin metabolism that is characterized by decreased levels of the coenzymes adenosylcobalamin and methylcobalamin. Pseudogenes have been identified on chromosomes 11 and X.[provided by RefSeq, Nov 2008]
MMADHC Gene-Disease associations (from GenCC):
  • inborn disorder of cobalamin metabolism and transport
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • methylmalonic aciduria and homocystinuria type cblD
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-149575863-C-G is Benign according to our data. Variant chr2-149575863-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260678.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.838 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMADHCNM_015702.3 linkc.479-22G>C intron_variant Intron 5 of 7 ENST00000303319.10 NP_056517.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMADHCENST00000303319.10 linkc.479-22G>C intron_variant Intron 5 of 7 1 NM_015702.3 ENSP00000301920.5
MMADHCENST00000422782.2 linkc.479-22G>C intron_variant Intron 5 of 8 5 ENSP00000408331.2
MMADHCENST00000428879.5 linkc.479-22G>C intron_variant Intron 4 of 6 2 ENSP00000389060.1

Frequencies

GnomAD3 genomes
AF:
0.649
AC:
98502
AN:
151850
Hom.:
35618
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.303
Gnomad AMI
AF:
0.754
Gnomad AMR
AF:
0.658
Gnomad ASJ
AF:
0.801
Gnomad EAS
AF:
0.859
Gnomad SAS
AF:
0.766
Gnomad FIN
AF:
0.850
Gnomad MID
AF:
0.728
Gnomad NFE
AF:
0.791
Gnomad OTH
AF:
0.672
GnomAD2 exomes
AF:
0.751
AC:
168708
AN:
224514
AF XY:
0.759
show subpopulations
Gnomad AFR exome
AF:
0.293
Gnomad AMR exome
AF:
0.706
Gnomad ASJ exome
AF:
0.811
Gnomad EAS exome
AF:
0.858
Gnomad FIN exome
AF:
0.850
Gnomad NFE exome
AF:
0.783
Gnomad OTH exome
AF:
0.757
GnomAD4 exome
AF:
0.772
AC:
1081754
AN:
1401388
Hom.:
422844
Cov.:
24
AF XY:
0.773
AC XY:
539225
AN XY:
697548
show subpopulations
African (AFR)
AF:
0.278
AC:
8981
AN:
32322
American (AMR)
AF:
0.697
AC:
29287
AN:
42014
Ashkenazi Jewish (ASJ)
AF:
0.801
AC:
19982
AN:
24956
East Asian (EAS)
AF:
0.873
AC:
34004
AN:
38958
South Asian (SAS)
AF:
0.760
AC:
61973
AN:
81564
European-Finnish (FIN)
AF:
0.847
AC:
44028
AN:
51978
Middle Eastern (MID)
AF:
0.749
AC:
4170
AN:
5568
European-Non Finnish (NFE)
AF:
0.784
AC:
835366
AN:
1065898
Other (OTH)
AF:
0.756
AC:
43963
AN:
58130
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
9515
19030
28546
38061
47576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19628
39256
58884
78512
98140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.648
AC:
98521
AN:
151966
Hom.:
35624
Cov.:
33
AF XY:
0.653
AC XY:
48479
AN XY:
74274
show subpopulations
African (AFR)
AF:
0.302
AC:
12500
AN:
41368
American (AMR)
AF:
0.658
AC:
10053
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.801
AC:
2781
AN:
3470
East Asian (EAS)
AF:
0.859
AC:
4432
AN:
5160
South Asian (SAS)
AF:
0.767
AC:
3695
AN:
4818
European-Finnish (FIN)
AF:
0.850
AC:
9008
AN:
10594
Middle Eastern (MID)
AF:
0.728
AC:
211
AN:
290
European-Non Finnish (NFE)
AF:
0.791
AC:
53734
AN:
67972
Other (OTH)
AF:
0.673
AC:
1421
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1446
2892
4338
5784
7230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.709
Hom.:
5319
Bravo
AF:
0.618
Asia WGS
AF:
0.789
AC:
2711
AN:
3438

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Methylmalonic aciduria and homocystinuria type cblD Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.85
DANN
Benign
0.66
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12232959; hg19: chr2-150432377; COSMIC: COSV57574667; API